Ario Pharma (TRPV1 antagonist asset)

Business Data, Corporate Office and Headquarter Address

About

Ario Pharma (TRPV1 antagonist asset) is Buildings and Property in United Kingdom that focus on United Kingdom business. They cover business area such as England, United Kingdom, a series, patent, know-how, datum.

Business Type

Buildings and Property

Country

United Kingdom

Founded

-

Company Focus

United Kingdom

Website

-

Corporate Office and Headquarter Office address:

Cambridge
England, United Kingdom

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

EnglandUnited Kingdoma seriespatentknow-howdatum

* We use standard office opening hours in near Ario Pharma (TRPV1 antagonist asset)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Ario Pharma (TRPV1 antagonist asset) Frequently Asked Questions

What or who is Ario Pharma (TRPV1 antagonist asset)?

Ario Pharma (TRPV1 Antagonist Asset) is Buildings and Property business from United Kingdom that founded in - ( years old in ), Ario Pharma (TRPV1 antagonist asset) business is focusing on United Kingdom.

Where is Ario Pharma (TRPV1 antagonist asset) headquarter and corporate office address?

Ario Pharma (TRPV1 antagonist asset) headquarter office and corporate office address is located in Cambridge England, United Kingdom.

Where is Ario Pharma (TRPV1 antagonist asset) country origins?

Ario Pharma (TRPV1 antagonist asset) was founded in United Kingdom.

What is United Kingdom business focus on?

In , Ario Pharma (TRPV1 antagonist asset) is currently focus on United Kingdom sector.

United Kingdom Business Interest from Google Trend

Above is snippet of Google Trends for "United Kingdom" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with Ario Pharma (TRPV1 antagonist asset), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.